Kaleo Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KALEO INC, and what generic alternatives to KALEO INC drugs are available?
KALEO INC has four approved drugs.
There are thirty-nine US patents protecting KALEO INC drugs.
There are one hundred and forty-four patent family members on KALEO INC drugs in fifteen countries and one supplementary protection certificate in one country.
Drugs and US Patents for Kaleo Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kaleo Inc | NALOXONE HYDROCHLORIDE (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 215457-001 | Feb 28, 2022 | DISCN | Yes | No | 10,143,792 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-003 | Nov 17, 2017 | RX | Yes | No | 8,608,698 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Kaleo Inc | NALOXONE HYDROCHLORIDE (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 215457-001 | Feb 28, 2022 | DISCN | Yes | No | 10,314,977 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 8,226,610 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | 8,939,943 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | 8,425,462 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kaleo Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2008528210 | ⤷ Try a Trial |
United Kingdom | 0910105 | ⤷ Try a Trial |
Mexico | 2010012334 | ⤷ Try a Trial |
United Kingdom | 201109680 | ⤷ Try a Trial |
European Patent Office | 1814611 | ⤷ Try a Trial |
Canada | 3029371 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kaleo Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.